<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>fedlex-data-admin-ch-eli-fga-2023-687-fr-docx</title>
</head>
<body><div id="lawcontent"><div id="preface">
<h1 class="erlasstitel botschafttitel ">Notifications et demandes d’autorisation pour des activités impliquant des organismes génétiquement modifiés ou pathogènes en milieu confiné</h1>
<p class="untertit man-font-weight-bold ">Notifications et demandes d’autorisation reçues <br>du 01.11.2022 au 28.02.2023</p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<th class=" man-text-align-left ">
					
					<p>Numéro</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Date de réception</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Canton concerné</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Requérant /<br>Emplacement de l’entreprise</p>
				</th>
				<th class=" man-text-align-left ">
					
					<p>Titre abrégé du projet</p>
				</th>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000009-02</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>C. Chuard</p>
					<p>Laboratoire de microbiologie de l’hôpital cantonal</p>
					<p>Ch. des Pensionnats<br>1708 Fribourg</p>
				</td>
				<td>
					
					<p>Diagnostic des maladies infectieuses</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000062-05</p>
				</td>
				<td>
					
					<p>15.12.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Mariagrazia Uguccioni</p>
					<p>Institute for Research in Biomedicine</p>
					<p>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Molecular mechanisms of signal transduction</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A000683-05</p>
				</td>
				<td>
					
					<p>22.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Paul Heuberger</p>
					<p>Novartis Pharma AG</p>
					<p>Postfach<br>4002 Basel</p>
				</td>
				<td>
					
					<p>Microbiological quality controls for Novartis Pharma AG site Basel</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A040505-02</p>
				</td>
				<td>
					
					<p>15.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Dominique Velin</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Ch. des Boveresses 155<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Etude des mécanismes immunitaires impliqués dans les pathologies inflammatoires de l’intestion et développement d’une vaccination dirigée contre Helicobacter pylori</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A070238-01</p>
				</td>
				<td>
					
					<p>09.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Sybille Schwendener</p>
					<p>Universität Zürich, Zentrum für Zahnmedizin, Klinik für Zahnerhaltung und Präventivzahnmedizin</p>
					<p>Plattenstrasse<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Virulence factors and resistance mechanisms of multispecies oral biofilms</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A080062-03</p>
				</td>
				<td>
					
					<p>30.11.2022</p>
				</td>
				<td>
					
					<p>ZG</p>
				</td>
				<td>
					
					<p>Markus Kulstrunk</p>
					<p>Roche Diagnostics International AG</p>
					<p>Forrenstrasse 2<br>6343 Rotkreuz</p>
				</td>
				<td>
					
					<p>HIV, HBV, HCV – Diagnostische Testentwicklung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A081045-03</p>
				</td>
				<td>
					
					<p>07.11.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Corinne Plumety</p>
					<p>Estavayer Lait SA</p>
					<p>Route de Payerne<br>1470 Estavayer-le-Lac</p>
				</td>
				<td>
					
					<p>Laboratoire de microbiologie de denrées alimentaires pour notre site de production (Estavayer Lait SA) à 1470 Estavayer-le-Lac.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A090105-13</p>
				</td>
				<td>
					
					<p>14.12.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Caroline Tapparel Vu</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Picornavirus respiratoires: variabilité génomique et adaptation</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A100815-02</p>
				</td>
				<td>
					
					<p>19.02.2023</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Andreas Muehlemann</p>
					<p>Idorsia Pharmaceuticals Ltd.</p>
					<p>Hegenheimermattweg 91<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Use of shRNA delivered by recombinant lentivirus expression system.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A110109-03</p>
				</td>
				<td>
					
					<p>25.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Nicole Déglon</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Av. de Beaumont, Bâtiment des laboratoires<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Gene transfer for the modeling and treatment of neurodegeneratives diseases</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120558-01</p>
				</td>
				<td>
					
					<p>30.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Angela Ciuffi</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 48<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>HIV latency</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120566-07</p>
				</td>
				<td>
					
					<p>30.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Conrad Curdin</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 7 / 9<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Notification globale de classe 1 du CHUV</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120702-09</p>
				</td>
				<td>
					
					<p>01.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Alex Hall</p>
					<p>ETHZ, Department USYS, Institute of Integrative Biology, Pathogen Ecology Group</p>
					<p>Universitätsstrasse<br>8092 Zürich</p>
				</td>
				<td>
					
					<p>Evolution of antibiotic resistance</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120799-09</p>
				</td>
				<td>
					
					<p>27.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Christof Holliger</p>
					<p>EPFL - ENAC Faculté de l’Environnement Naturel, Architectural et Construit</p>
					<p>Station<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Ingénierie de l’environnement</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120851-26</p>
				</td>
				<td>
					
					<p>02.02.2023</p>
				</td>
				<td>
					
					<p>VD, <br>GE</p>
				</td>
				<td>
					
					<p>Brian McCabe</p>
					<p>EPFL – SV Faculté des sciences de la vie</p>
					<p>Station 19<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Recherche en sciences de la vie</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120866-10</p>
				</td>
				<td>
					
					<p>05.12.2022</p>
				</td>
				<td>
					
					<p>VD, <br>NE, <br>GE</p>
				</td>
				<td>
					
					<p>Martinus Gijs</p>
					<p>EPFL – STI Faculté Sciences et Techniques de l’Ingénieur</p>
					<p>Station 12<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Recherche en sciences et techniques</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A120907-05</p>
				</td>
				<td>
					
					<p>23.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Maria Cristina Gambetta</p>
					<p>UNIL – Centre Intégratif de Génomique (CIG)</p>
					<p>Bâtiment Génopode<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Notification globale d’activité de classe 1 – UNIL – Centre Intégratif de Génomique (CIG)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130512-09</p>
				</td>
				<td>
					
					<p>09.02.2023</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Xavier Perret</p>
					<p>Université de Genève, Sciences III</p>
					<p>rue de l’Ecole de Médecine<br>1211 Genève 4</p>
				</td>
				<td>
					
					<p>Globalmeldung der Université de Genève, Sciences III</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130556-10</p>
				</td>
				<td>
					
					<p>16.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Jean-Christophe Leroux</p>
					<p>ETHZ, Departement CHAB, Institut für Pharmazeutische Wissenschaften, Drug formulation + delivery</p>
					<p>Vladimir Prelog-Weg 1-5/10<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Globalmeldung der ETH Zürich, Gruppe Leroux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130565-05</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Julien Alassimone</p>
					<p>ETHZ, Departement USYS, Institut für Pflanzenwissenschaften, Phytopathologie</p>
					<p>Universitätsstrasse<br>8092 Zürich</p>
				</td>
				<td>
					
					<p>Pflanzenpathologische Forschung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A130946-06</p>
				</td>
				<td>
					
					<p>04.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Jörg Schreiber</p>
					<p>ETHZ, Departement BSSE, Department of Biosystems Science and Engineering | Department of Biosystems Science and Engineering</p>
					<p>Mattenstrasse<br>4058 Basel</p>
				</td>
				<td>
					
					<p>Generation of viral vectors and packaging cells that use gene products derived from adenovirus and adeno-associated virus</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A131040-07</p>
				</td>
				<td>
					
					<p>19.02.2023</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Daniel Ritz</p>
					<p>Idorsia Pharmaceuticals Ltd.</p>
					<p>Hegenheimermattweg 91<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Globalmeldung Idorsia Pharmaceuticals Ltd.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A141398-03</p>
				</td>
				<td>
					
					<p>12.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Attila Becskei</p>
					<p>Universität Basel, Biozentrum / Pharmazentrum</p>
					<p>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Microbial analysis of oral and skin flora</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A141409-02</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p>VS</p>
				</td>
				<td>
					
					<p>Emilie Patois</p>
					<p>TRB CHEMEDICA SA</p>
					<p>chemin St-Marc<br>1896 Vouvry</p>
				</td>
				<td>
					
					<p>Recherche et Développement</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A151538-07</p>
				</td>
				<td>
					
					<p>05.01.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Kristina Schmidt</p>
					<p>Labor Spiez</p>
					<p>Austrasse<br>3700 Spiez</p>
				</td>
				<td>
					
					<p>Entwicklung und Durchführung von Tests für die Evaluation von antiviralen Substanzen, neutralisierenden Antikörpern und Dekontaminationslösungen gegen Viren der Risikogruppe 2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161706-02</p>
				</td>
				<td>
					
					<p>13.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Ralph Müller</p>
					<p>ETHZ, Departement HEST, Institut für Biomechanik, Gruppe Müller</p>
					<p>Leopold-Ruzicka-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>ETH Zürich, Institut für Biomechanik, Gruppe Müller BSL-2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161828-06</p>
				</td>
				<td>
					
					<p>31.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Philippe Reymond</p>
					<p>UNIL – Département de Biologie moléculaire et végétale (DBMV)</p>
					<p>Bâtiment Biophore<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>UNIL_DBMV_Notification globale niveau 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A161846-02</p>
				</td>
				<td>
					
					<p>16.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Paola Bezzi</p>
					<p>UNIL – Département des neurosciences fondamentales (DNF)</p>
					<p>Rue du Bugnon<br>1005 Lausanne</p>
				</td>
				<td>
					
					<p>UNIL_DNF_Notification globale niveau 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A171974-02</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Naja Nyffenegger</p>
					<p>Vifor (International) AG</p>
					<p>Wagistrasse<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Bsl2 Cell Culture Lab Schlieren</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A172162-01</p>
				</td>
				<td>
					
					<p>22.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Philipp Richle</p>
					<p>CDR-Life AG</p>
					<p>Wagistrasse 27<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Development of therapeutic antibody fragments and constructs thereof</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182206-01</p>
				</td>
				<td>
					
					<p>03.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Caroline Pot Kreis</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Ch. des Boveresses 155<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Study of immune regulation during autoimmunity.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182238-01</p>
				</td>
				<td>
					
					<p>09.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Florent Allagnat</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 7/9<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Etude de la fonction vasculaire à partir de segments de veines humaines</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182239-01</p>
				</td>
				<td>
					
					<p>22.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Laurence de Leval</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 25<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Création de modèles cellulaires in vitro pour l’étude des lymphomes</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182260-03</p>
				</td>
				<td>
					
					<p>06.01.2023</p>
				</td>
				<td>
					
					<p>LU</p>
				</td>
				<td>
					
					<p>Daniela von Allmen</p>
					<p>Andermatt Biocontrol Suisse AG</p>
					<p>Stahlermatten 6<br>6146 Grossdietwil</p>
				</td>
				<td>
					
					<p>Insektenzuchten Klasse 3</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182395-04</p>
				</td>
				<td>
					
					<p>20.02.2023</p>
				</td>
				<td>
					
					<p>NE</p>
				</td>
				<td>
					
					<p>Richard Van Ewijk</p>
					<p>Ichnos Sciences SA | NE</p>
					<p>Chemin de la Combeta 5<br>2300 La chaux de fonds</p>
				</td>
				<td>
					
					<p>Global notification La Chaux‑de-Fonds</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182437-03</p>
				</td>
				<td>
					
					<p>30.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Karl Gademann</p>
					<p>Universität Zürich | Institut für Chemie</p>
					<p>Winterthurerstrasse 190<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Evaluation antimicrobial properties</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A182444-01</p>
				</td>
				<td>
					
					<p>01.11.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Mirko Trajkovski</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Study of metabolic and inflammatory pathways</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A192581-01</p>
				</td>
				<td>
					
					<p>12.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Kateryna Tolmachova</p>
					<p>ETHZ, Departement CHAB, Laboratorium für Organische Chemie, Bode group | Labs HCI F302 and HCI E320</p>
					<p>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>BSL2 research activity – ROS mediated small molecule activation</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A192632-05</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>NE</p>
				</td>
				<td>
					
					<p>Christèle Borgeaud</p>
					<p>Université de Neuchâtel, Institut de biologie</p>
					<p>Rue Emile-Argand<br>2000 Neuchâtel</p>
				</td>
				<td>
					
					<p>Chemical ecology of plant-insect interactions – rearing of arthropods for experiments</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A192743-01</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Urs Frey</p>
					<p>MaxWell Biosystems AG</p>
					<p>Albisriederstrasse<br>8047 Zürich</p>
				</td>
				<td>
					
					<p>Microelectrode array cell culturing</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202841-01</p>
				</td>
				<td>
					
					<p>06.02.2023</p>
				</td>
				<td>
					
					<p>ZG</p>
				</td>
				<td>
					
					<p>Sabine Locher</p>
					<p>Roche Diagnostics International AG</p>
					<p>Forrenstrasse 2<br>6343 Rotkreuz</p>
				</td>
				<td>
					
					<p>cobas Malaria</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202945-01</p>
				</td>
				<td>
					
					<p>12.12.2022</p>
				</td>
				<td>
					
					<p>ZG</p>
				</td>
				<td>
					
					<p>Susanne Ruhstorfer</p>
					<p>Roche Diagnostics International AG</p>
					<p>Forrenstrasse 2<br>6343 Rotkreuz</p>
				</td>
				<td>
					
					<p>Cobas Hematology</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202952-04</p>
				</td>
				<td>
					
					<p>08.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Priscilla Turelli</p>
					<p>EPFL – SV Faculté des sciences de la vie</p>
					<p>Station 19<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Improvement of tools to detect specific neutralizing antibodies against SARS-CoV-2 and study of the virus replication and virus-host cell interactions.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A202957-01</p>
				</td>
				<td>
					
					<p>07.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Richard Chahwan</p>
					<p>University of Zurich, Institute of Experimental Immunology, Cancer Immunobiology Lab | Y23 K68 | Winterthurerstrasse 190, 8057, Zurich</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Gene editing in immunity and cancer</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203043-01</p>
				</td>
				<td>
					
					<p>13.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Stephanie Kueng</p>
					<p>F. Hoffmann-La Roche AG, pRED Therapeutic Modalities</p>
					<p>Grenzacherstrasse<br>4070 Basel</p>
				</td>
				<td>
					
					<p>Cell based assay development for drug discovery</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203045-02</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Claudia Senn</p>
					<p>F. Hoffmann-La Roche AG, Pharmaceutical Sciences</p>
					<p>Grenzacherstrasse<br>4070 Basel</p>
				</td>
				<td>
					
					<p>Exploratory pharmacology of Adeno-associated virus (AAV) mediated gene transfer in mice</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203049-02</p>
				</td>
				<td>
					
					<p>17.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Andreas Mayer</p>
					<p>UNIL – Département de Biochimie (DB)</p>
					<p>Chemin des Boveresses<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>UNIL-Département de Biochimie_Notification globale de niveau 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A203081-02</p>
				</td>
				<td>
					
					<p>06.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Klaus Eyer</p>
					<p>ETHZ, Departement CHAB, Institut für Pharmazeutische Wissenschaften, FIBA, Gruppe Eyer</p>
					<p>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Functional single-cell analysis</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210108-01</p>
				</td>
				<td>
					
					<p>08.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Fanny Langlet</p>
					<p>UNIL – Département des Sciences Biomédicales</p>
					<p>Bugnon<br>1005 Lausanne</p>
				</td>
				<td>
					
					<p>Deciphering tanycyte/neuron communications</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210117-01</p>
				</td>
				<td>
					
					<p>09.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Gregory Resch</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Av. de Beaumont, Bâtiment des Laboratoires<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Développement de bactériophages dirigées contre les principaux pathogènes bactériens humains</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210156-01</p>
				</td>
				<td>
					
					<p>17.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Peter Szövenyi</p>
					<p>Institut für Systematische und Evolutionäre Botanik, Universität Zürich</p>
					<p>Zollikerstrasse 107<br>8008 Zürich</p>
				</td>
				<td>
					
					<p>Evlutionare Entwicklungsbiologie von Bryophytena und Farnen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210169-01</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Ronald Dijkman</p>
					<p>Universität Bern, Institut für Infektionskrankheiten | Institut für Infektionskrankheiten</p>
					<p>Friedbühlstrasse 51<br>3001 BERN</p>
				</td>
				<td>
					
					<p>Characterization of virus – host interaction dynamics within the respiratory epithelium of different host species</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210187-01</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Valeria Cagno</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 48<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Neutralization tests and antiviral research for Flaviviruses</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210234-01</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Jen Champoux</p>
					<p>Monte Rosa Therapeutics AG</p>
					<p>Klybeckstrasse 191 – WKL 136.3<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Analytical assays using primary human cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210255-01</p>
				</td>
				<td>
					
					<p>08.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Helena Villuendas García</p>
					<p>ETHZ, Departement MAVT, Nanophotonics Systems Lab, Gruppe Quidant</p>
					<p>Tannenstrasse 3, CLA<br>8092 Zurich</p>
				</td>
				<td>
					
					<p>Hyperthermia of cancer cells level 1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210272-02</p>
				</td>
				<td>
					
					<p>21.11.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Serge Rudaz</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Targeted and untargeted metabolomic phenotyping of diverse biological samples</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210280-01</p>
				</td>
				<td>
					
					<p>22.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Alexander Mathys</p>
					<p>ETHZ, Departement HEST, IFNH, Sustainable Food Processing, Gruppe Mathys</p>
					<p>Schmelzbergstrasse<br>8092 Zürich</p>
				</td>
				<td>
					
					<p>Microalgae, fungi and bacteria research for sustainable food processing </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210293-01</p>
				</td>
				<td>
					
					<p>28.11.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Patrycja Nowak-Sliwinska</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>rue Michel Servet<br>1206 Genève</p>
				</td>
				<td>
					
					<p>CMU_global class 1 notification</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A210296-01</p>
				</td>
				<td>
					
					<p>19.02.2023</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Barbara Channer</p>
					<p>Idorsia Pharmaceuticals Ltd.</p>
					<p>Gewerbestrasse 14<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Microbiological quality control laboratory for the testing of pharmaceutical samples</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220020-02</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Carolyn King</p>
					<p>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel</p>
					<p>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Mycobacterium tuberculosis for use in vitro and in mouse models</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220035-01</p>
				</td>
				<td>
					
					<p>04.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Souzan Salemi</p>
					<p>USZ, Urologische Klinik</p>
					<p>Wagistrasse 21<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>LentiCRISPRv2 </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220050-01</p>
				</td>
				<td>
					
					<p>27.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Matthias Hofmann</p>
					<p>Lonza AG, DPS</p>
					<p>Hochbergerstrasse<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Zelllinien basierte Assays </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220053-01</p>
				</td>
				<td>
					
					<p>21.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Julie Bénis</p>
					<p>Biosafe Group SA</p>
					<p>Allée des moulins 3<br>1274 Grens</p>
				</td>
				<td>
					
					<p>Controle microbiologique pour la production de consommables médicaux</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220068-01</p>
				</td>
				<td>
					
					<p>18.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Sophia Zeng</p>
					<p>OPNA Immuno-Oncology SA</p>
					<p>OPNA Immuno-Oncology SA Biopôle 6, Route de la Corniche Bâtiment Serine<br>1066 Epalniges</p>
				</td>
				<td>
					
					<p>Use of BSL2 lentivirus and BSL1 organisms at OPNA</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220075-01</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Simone Steiner</p>
					<p>Tigen Pharma SA</p>
					<p>Route de la Corniche 6<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Technical development of cell therapies</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220089-02</p>
				</td>
				<td>
					
					<p>15.12.2022</p>
				</td>
				<td>
					
					<p>ZG</p>
				</td>
				<td>
					
					<p>Michael Glauser</p>
					<p>Roche Diagnostics International AG</p>
					<p>Forrenstrasse 2<br>6343 Rotkreuz</p>
				</td>
				<td>
					
					<p>Diagnostische Arbeiten für die Vorentwicklung von prä-/post-analytik Geräten und Analyzer</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220107-01</p>
				</td>
				<td>
					
					<p>30.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Franz Schuler</p>
					<p>F. Hoffmann-La Roche AG, DTA Immunology and Inflammation</p>
					<p>Grenzacherstrasse<br>4070 Basel</p>
				</td>
				<td>
					
					<p>Investigation of novel markers and targets in the treatment of inflammatory and autoimmune diseases</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220134-02</p>
				</td>
				<td>
					
					<p>19.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cristina Porcheri</p>
					<p>University of Zurich – Orofacial Development and Regeneration</p>
					<p>Plattenstrasse 11<br>8032 Zürich</p>
				</td>
				<td>
					
					<p>Global notification</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220184-01</p>
				</td>
				<td>
					
					<p>04.11.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Marcus Haag</p>
					<p>Université de Fribourg. Departement de Médicine, Department of Neurosciences and Movement Sciences</p>
					<p>Chemin du Musee 6, Section of Medicine<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Usage of adeno-asssociated optogentic viruses </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220188-01</p>
				</td>
				<td>
					
					<p>03.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Matthias Bozza</p>
					<p>Vector BioPharma AG</p>
					<p>Hochbergerstrasse 60C<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Global notification</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220206-01</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Aleksandar Antanasijevic</p>
					<p>EPFL – SV Faculté des sciences de la vie</p>
					<p>Station 19<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Structure-based design and evaluation of vaccine candidates and antibodies against viral pathogens</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220245-01</p>
				</td>
				<td>
					
					<p>22.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Philipp Richle</p>
					<p>CDR-Life AG</p>
					<p>Wagistrasse 27<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Lentiviral particles</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220256-01</p>
				</td>
				<td>
					
					<p>06.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Steffen Kiessig</p>
					<p>ten23 health</p>
					<p>Mattenstrasse 22<br>4058 Basel</p>
				</td>
				<td>
					
					<p>Analysen, Validierung und Methodenentwicklung unter BSL-1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220265-01</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Thierry Soldati</p>
					<p>Université de Genève, Sciences II</p>
					<p>quai Ernest-Ansermet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Dictyostelium discoideum interaction with Xanthomonas citri</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220275-00</p>
				</td>
				<td>
					
					<p>01.11.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Kimberly Kline</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Understanding the pathogenic mechanisms of biofilm-associated bacterial Infections</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220276-00</p>
				</td>
				<td>
					
					<p>02.11.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Olivier Pascal Schären</p>
					<p>Universität Bern, Institut für Infektionskrankheiten | Institut für Infektionskrankheiten</p>
					<p>Friedbühlstrasse 51<br>3001 BERN</p>
				</td>
				<td>
					
					<p>Intestinal bacterial-induced immunity studied with attenuated pathogenic intestinal bacteria in SPF chicken</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220277-00</p>
				</td>
				<td>
					
					<p>09.11.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Peter Sagelsdorff</p>
					<p>Swiss BioQuant AG</p>
					<p>Kägenstrasse 18<br>4153 Reinach</p>
				</td>
				<td>
					
					<p>Determination of Cytokines and Drug Level in plasma / whole blood from COVID infected patiens (Phase II)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220278-00</p>
				</td>
				<td>
					
					<p>10.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Paulina Wyrzykowska</p>
					<p>University of Zurich, Institute of Experimental Immunology, Cancer Immunobiology Lab | Y23 K68 | Winterthurerstrasse 190, 8057, Zurich</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Cloning and molecular work</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220279-01</p>
				</td>
				<td>
					
					<p>23.11.2022</p>
				</td>
				<td>
					
					<p>NE</p>
				</td>
				<td>
					
					<p>Elisabeth Wagnair</p>
					<p>Celgene International</p>
					<p>Route de Perreux<br>2017 Boudry</p>
				</td>
				<td>
					
					<p>Laboratoire Contrôle Qualité Microbiologie: analyses Microbiologiques de matières premières et produits finis, controlé microbiologie des prélèvements environnementaux et d’eaux, tests de libération de milieux de cultures et validation de méthode </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220280-01</p>
				</td>
				<td>
					
					<p>30.11.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Tiago Ferreira</p>
					<p>Tenpoint Therapeutics GmbH</p>
					<p>Hegenheimermattweg 167A<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>P1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220281-00</p>
				</td>
				<td>
					
					<p>14.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Marcy Zenobi-Wong</p>
					<p>ETHZ, Departement HEST, Gruppe Zenobi-Wong</p>
					<p>Otto-Stern-Weg 7<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Light-mediated biofabrication of tissue constructs</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220282-00</p>
				</td>
				<td>
					
					<p>14.11.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Heike Schmidt-Posthaus</p>
					<p>Universität Bern, Zentrum für Fisch- und Wildtiermedizin (FIWI) Department of Infectious diseases and pathobiology (DIP)</p>
					<p>Länggassstrasse 122B<br>3001 Bern</p>
				</td>
				<td>
					
					<p>Arbeiten mit Tetracapsuloides bryosalmonae</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220283-00</p>
				</td>
				<td>
					
					<p>15.11.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Lucas Lüthy</p>
					<p>CTC Diagnostics AG</p>
					<p>Industriestrasse<br>4222 Zwingen</p>
				</td>
				<td>
					
					<p>Entwicklung der Automation der Sepsis-Diagnostik am Modell E.Coli</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220284-00</p>
				</td>
				<td>
					
					<p>16.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Marilena Palmisano</p>
					<p>ZHAW, Life Sciences und Facility Management</p>
					<p>Einsiedlerstrasse 31<br>8820 Wädenswil</p>
				</td>
				<td>
					
					<p>Hemp Seed Diagnostic</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220285-00</p>
				</td>
				<td>
					
					<p>17.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Annette Pleger</p>
					<p>Spital Uster</p>
					<p>Brunnenstrasse 42<br>8610 Uster</p>
				</td>
				<td>
					
					<p>Nachweis von säurefesten Stäbchen im Direktpräparat, Kinyoun-Färbung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220286-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anahita Rafiei</p>
					<p>ImmunOs Therapeutics AG</p>
					<p>Wagistrasse 14<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Isolation and Analysis of PBMCs from human whole blood of healthy volunteers</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220287-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anahita Rafiei</p>
					<p>ImmunOs Therapeutics AG</p>
					<p>Wagistrasse 14<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Viral Vector</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220288-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Salomé LeibundGut</p>
					<p>Universität Zürich | Virologisches Institut</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Untersuchung der Häufigkeit von Aspergillus Keimen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220289-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>michael eisenring</p>
					<p>Eidgenössische Forschungsanstalt WSL</p>
					<p>Zürcherstrasse<br>8903 Birmensdorf ZH</p>
				</td>
				<td>
					
					<p>Versuche zu Verhalten und biologischer Bekämpfung des Eschenprachtkäfers</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220290-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Camille Staehly</p>
					<p>Monte Rosa Therapeutics AG</p>
					<p>Klybeckstrasse 191 – WKL 136.3<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Use of iPSCs for study of diverse disease models</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220291-00</p>
				</td>
				<td>
					
					<p>18.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Pascal Rüedi</p>
					<p>ETHZ, Departement MAVT, Nanophotonics Systems Lab, Gruppe Quidant</p>
					<p>Tannenstrasse 3, CLA<br>8092 Zurich</p>
				</td>
				<td>
					
					<p>Cell secretion study inmune cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220292-01</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anahita Rafiei</p>
					<p>ImmunOs Therapeutics AG</p>
					<p>Wagistrasse 14<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>In vitro pharmacology experiments assessing potency and safety of biologics for tumor-targeted immunotherapies</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220293-00</p>
				</td>
				<td>
					
					<p>19.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anil Kumar</p>
					<p>ImmunOs Therapeutics AG</p>
					<p>Wagistrasse 14<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Development of therapeutic biologics and constructs thereof</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220294-00</p>
				</td>
				<td>
					
					<p>23.11.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Martin Degen</p>
					<p>Universität Bern, Zahnmedizinische Kliniken</p>
					<p>Freiburgstrasse<br>3010 Bern</p>
				</td>
				<td>
					
					<p>Lentiviral transduction of human cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220295-00</p>
				</td>
				<td>
					
					<p>23.11.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Claudia Bagutti</p>
					<p>Kantonales Laboratorium BS / Basel</p>
					<p>Kannenfeldstrasse<br>4056 Basel</p>
				</td>
				<td>
					
					<p>RISIKOABSCHÄTZUNGEN IM UMGANG MIT LENTIVIRALEN VEKTOREN</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220296-00</p>
				</td>
				<td>
					
					<p>24.11.2022</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Andreas Papassotiropoulos</p>
					<p>Universität Basel, Biozentrum / Pharmazentrum</p>
					<p>Klingelbergstrasse 50<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Using human-derived primary neuronal cells and iPSCs to study neuropsychiatric and neurodegenerative diseases</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220297-00</p>
				</td>
				<td>
					
					<p>25.11.2022</p>
				</td>
				<td>
					
					<p>BL</p>
				</td>
				<td>
					
					<p>Simon Josef Ittig</p>
					<p>T3 Pharmaceuticals AG</p>
					<p>Hegenheimermattweg 167 A<br>4123 Allschwil</p>
				</td>
				<td>
					
					<p>Bacteria as protein delivery tool</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220298-00</p>
				</td>
				<td>
					
					<p>25.11.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Aurélien LATHUILERE</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1, rue Michel Servet, CMU<br>1206 Geneva</p>
				</td>
				<td>
					
					<p>Probing toxic protein aggregates in neurodegenerative disorders using engineered biosensor cell lines</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220299-00</p>
				</td>
				<td>
					
					<p>25.11.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Stephan Rohr</p>
					<p>Universität Bern | Physiologisches Institut</p>
					<p>Bühlplatz<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Function of Neuronal Networks and Cardiac Muscle Tissue</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220300-01</p>
				</td>
				<td>
					
					<p>22.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Michela Manni</p>
					<p>GlycoEra AG</p>
					<p>Einsiedlerstrasse 34<br>8820 Wädenswil</p>
				</td>
				<td>
					
					<p>Immune cells isolation form Human Blood</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220301-00</p>
				</td>
				<td>
					
					<p>29.11.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Roman Spörri</p>
					<p>ETHZ, Departement BIOL, Institut für Mikrobiologie</p>
					<p>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Immunantwort auf Infektion mit rekombinanten LCM Viren</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220302-00</p>
				</td>
				<td>
					
					<p>01.12.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Ekaterine Berishvili Berney</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>1 Rue Michel Servet<br>1211 Genève</p>
				</td>
				<td>
					
					<p>Lentivirus transduction of human derived endothelial cells (BOECS and HUVECs) for GFP expression</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220303-00</p>
				</td>
				<td>
					
					<p>02.12.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Massimo Sabatino</p>
					<p>Ingenus Pharmaceuticals GmbH</p>
					<p>Cadepiano 24<br>6917 Barbengo</p>
				</td>
				<td>
					
					<p>Ingenus Pharmaceuticals GmbH</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220304-01</p>
				</td>
				<td>
					
					<p>06.12.2022</p>
				</td>
				<td>
					
					<p>SG</p>
				</td>
				<td>
					
					<p>Burkhard Ludewig</p>
					<p>Kantonsspital SG, Medizinisches Forschungszentrum (MFZ), Institut für Immunbiologie</p>
					<p>Haus 09<br>9007 St. Gallen</p>
				</td>
				<td>
					
					<p>Regulation of lymphoid organ fibroblast differentiation and function by bone morphogenic proteins</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220305-00</p>
				</td>
				<td>
					
					<p>06.12.2022</p>
				</td>
				<td>
					
					<p>AG</p>
				</td>
				<td>
					
					<p>Paulina Schärer</p>
					<p>Focal Biosciences AG</p>
					<p>Forschungsstrasse 111<br>5232 Villigen</p>
				</td>
				<td>
					
					<p>Global Notification of BSL-1 activities</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220306-00</p>
				</td>
				<td>
					
					<p>07.12.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Norbert Polacek</p>
					<p>Universität Bern, Departement für Chemie, Biochemie und Pharmazie</p>
					<p>Freiestrasse<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Investigation of the role of tRNA-derived fragments in neurodegeneration of Alzheimer’s Disease</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220307-00</p>
				</td>
				<td>
					
					<p>09.12.2022</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Guillaume Kuhn</p>
					<p>Université de Fribourg, Département de Biologie</p>
					<p>Chemin du musée 10<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Honeypot</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220308-01</p>
				</td>
				<td>
					
					<p>12.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Gaku Akimoto</p>
					<p>ETHZ, Departement CHAB, Laboratorium für Organische Chemie, Bode group | Labs HCI F302 and HCI E320</p>
					<p>Vladimir-Prelog-Weg<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>BSL1 cell culture research activities of the Bode group, LOC, ETHZ</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220309-00</p>
				</td>
				<td>
					
					<p>13.12.2022</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Mariagrazia Uguccioni</p>
					<p>Institute for Research in Biomedicine</p>
					<p>via Francesco Chiesa 5<br>6500 Bellinzona</p>
				</td>
				<td>
					
					<p>Identification of cell surface receptors for ligands with chemotactic or motogenic activity</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220310-00</p>
				</td>
				<td>
					
					<p>14.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cornel Fraefel</p>
					<p>Universität Zürich | Virologisches Institut</p>
					<p>Winterthurerstr. 190<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Isolation and molecular characterization of Alongshan virus (ALSV)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220311-00</p>
				</td>
				<td>
					
					<p>15.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Romuald Houdré</p>
					<p>EPFL – SB Faculté des sciences de base</p>
					<p>Station<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Antibiotic and bacteriophage susceptibility testing on optofluidic chips</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220312-00</p>
				</td>
				<td>
					
					<p>16.12.2022</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Kinga IGLOI</p>
					<p>Fondation campus Biotech Geneva</p>
					<p>Chemin des Mines<br>1202 Genève</p>
				</td>
				<td>
					
					<p>Analyse de biomarqueurs salivaires et sanguins</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220313-00</p>
				</td>
				<td>
					
					<p>21.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Matthias Lutolf</p>
					<p>Roche Glycart AG | Roche Innovation Center Zurich | Roche Pharma Research and Early Development</p>
					<p>Wagistrasse 10<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Research and development of predictive tools for therapeutic research</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220314-00</p>
				</td>
				<td>
					
					<p>21.12.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Cristina Lorena Vacar</p>
					<p>Geographisches Institut, Universität Bern</p>
					<p>Friedbühlstrasse 51<br>3001 Bern</p>
				</td>
				<td>
					
					<p>Work with Fusarium oxysporum</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220315-01</p>
				</td>
				<td>
					
					<p>17.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Bithi Chatterjee</p>
					<p>Hengrui Europe Biosciences AG</p>
					<p>Bändliweg 30<br>8048 Zürich</p>
				</td>
				<td>
					
					<p>Biological activities with risk group 1 organisms</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220316-00</p>
				</td>
				<td>
					
					<p>22.12.2022</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Sabrina Cavin</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Use of lentiviral vectors to generate cancer cell lines expressing luciferase or fluorescent reporter genes.</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220317-00</p>
				</td>
				<td>
					
					<p>22.12.2022</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Kristina Stutzmann</p>
					<p>Inselspital Bern, Institut für klinische Chemie</p>
					<p>Tiefenaustrasse 112<br>3004 Bern</p>
				</td>
				<td>
					
					<p>Nachweis von SARS-CoV-2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A220318-00</p>
				</td>
				<td>
					
					<p>23.12.2022</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Mark Tibbitt</p>
					<p>ETH Zurich, D-MAVT, Macromolecular Engineering Laboratory</p>
					<p>Sonneggstrasse 3<br>8092 Zurich</p>
				</td>
				<td>
					
					<p>Meldung für Gruppe Tibbitt – BSL-2</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230001-00</p>
				</td>
				<td>
					
					<p>05.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Francesc Baixauli</p>
					<p>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel</p>
					<p>Hebelstrasse<br>4031 Basel</p>
				</td>
				<td>
					
					<p>The Role of PHGDH in normal and pathogenic CD4+T cell immunity </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230002-00</p>
				</td>
				<td>
					
					<p>05.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Robert Orr</p>
					<p>Pattern BioSciences AG</p>
					<p>Mattenstrasse 22 WRO 1059<br>4058 Basel</p>
				</td>
				<td>
					
					<p>Pattern BioSciences Class 1 Global</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230003-00</p>
				</td>
				<td>
					
					<p>05.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Chantal Pauli</p>
					<p>USZ, Institut für Pathologie und Molekularpathologie</p>
					<p>Schmelzbergstrasse<br>8091 Zürich</p>
				</td>
				<td>
					
					<p>Etablierung und Kultivierung von primären humanen Tumorzellkulturen für in vitro und in vivo Testung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230004-00</p>
				</td>
				<td>
					
					<p>06.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Bartolomeo Angelici</p>
					<p>Pattern BioSciences AG</p>
					<p>Mattenstrasse 22 WRO 1059<br>4058 Basel</p>
				</td>
				<td>
					
					<p>Research and development of gene therapy candidates</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230005-00</p>
				</td>
				<td>
					
					<p>06.01.2023</p>
				</td>
				<td>
					
					<p>LU</p>
				</td>
				<td>
					
					<p>Daniela von Allmen</p>
					<p>Andermatt Biocontrol Suisse AG</p>
					<p>Stahlermatten 6<br>6146 Grossdietwil</p>
				</td>
				<td>
					
					<p>Lagerung durch Handel mit Organismen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230006-00</p>
				</td>
				<td>
					
					<p>09.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Liliane Michalik</p>
					<p>UNIL – Centre Intégratif de Génomique (CIG)</p>
					<p>Genopode Quartier UNIL Sorge<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Study of the role of PPARbeta in skin</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230007-00</p>
				</td>
				<td>
					
					<p>09.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Daniel Goldenberger</p>
					<p>Universitätsspital Basel | Mikrobiologielabor | Labormedizin</p>
					<p>Petergraben 4<br>4031 Basel</p>
				</td>
				<td>
					
					<p>Meldung medizinisch-mikrobiologische Diagnostik von Gruppe 2-Erregern</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230008-00</p>
				</td>
				<td>
					
					<p>10.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Thomas Radimerski</p>
					<p>Ridgeline Discovery GmbH</p>
					<p>Hochbergerstrasse 60F<br>4057 Basel</p>
				</td>
				<td>
					
					<p>Lentivirus production and transduction </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230009-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Pierre Rossi</p>
					<p>EPFL – ENAC Faculté de l’Environnement Naturel, Architectural et Construit</p>
					<p>Station<br>1015 Lausanne</p>
				</td>
				<td>
					
					<p>Probiotic effect on bacterial growth</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230010-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Optimization of long-term storage for preservation of the human gut microbiome from stool samples</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230011-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>In-depth phenotypic and genotypic characterization of Capnocytophaga canimorsus from human and animal origin</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230012-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Characterization of ESBL displacing E. coli strains in the human gut microbiome and its effect on the gut microbiome composition over time. </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230013-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Discovery of biomarker prediction of invasive E. coli strains by MALDI-TOF MS</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230014-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Prediction of carbapenemase positive strains directly from MALDI-TOF MS spectra</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230015-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Identification of human food pathogens directly from food sources by shotgun metagenomics</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230016-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Rapid screening for multidrug resistant bacterial strains by shotgun metagenomic sequencing. </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230017-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>External consulting/collaborations on 16S metagenomic sequencing</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230018-00</p>
				</td>
				<td>
					
					<p>11.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Judith Zimmermann</p>
					<p>ETHZ, Student Project House</p>
					<p>Otto-​Stern-Weg 3<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>ETH Student Project House Biolab</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230019-00</p>
				</td>
				<td>
					
					<p>12.01.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Véronique Bernier Gosselin</p>
					<p>Universität Bern, Abteilung für Neurologische Wissenschaften</p>
					<p>Bremgartenstr.109a<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Detection of mastitis pathogens</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230020-00</p>
				</td>
				<td>
					
					<p>12.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Franz Emmenegger</p>
					<p>Evitria AG</p>
					<p>Wagistrasse 25<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>In vitro Herstellung von rekombinanten Proteinen in Säugetierzellen</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230021-00</p>
				</td>
				<td>
					
					<p>12.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Julien Puyal</p>
					<p>UNIL - Département des neurosciences fondamentales (DNF)</p>
					<p>Rue du Bugnon 9<br>1005 Lausanne</p>
				</td>
				<td>
					
					<p>Autophagy in primary brain cells</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230022-00</p>
				</td>
				<td>
					
					<p>13.01.2023</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Urs Albrecht</p>
					<p>Université de Fribourg, Département de Biologie</p>
					<p>Ch. du Musée 5<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>Molecular mechanisms of light-driven regulation of dispair and clock resetting</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230023-00</p>
				</td>
				<td>
					
					<p>16.01.2023</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Amandine Guérin</p>
					<p>Université de Genève, CMU (Centre Médical Universitaire)</p>
					<p>rue Michel Servet<br>1206 Genève</p>
				</td>
				<td>
					
					<p>Understanding the function of secreted proteins in the context of Cryptosporidiosis</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230024-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>External consulting/collaborations on bacterial phenotypic characterization by MALDI-TOF Mass Spectrometry analysis and Biolog technologies. </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230025-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Rapid pathogen detection in central nervous system infections </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230026-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastrasse 30<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Personalized management in allogeneic hematopoietic stem cell transplantation using multi-omics predictive biomarkers and microbial community modeling</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230027-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Adrian Egli</p>
					<p>Universität Zürich Institut für Medizinische Mikrobiologie</p>
					<p>Gloriastr.<br>8006 Zürich</p>
				</td>
				<td>
					
					<p>Discovery of new biomarkers for early detection of sepsis and prediction of sepsis-related mortality in patients with severe community acquired pneumonia (sCAP). </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230028-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Virginie Mansuy-Aubert</p>
					<p>UNIL – Département des Sciences Biomédicales</p>
					<p>Bugnon<br>1005 Lausanne</p>
				</td>
				<td>
					
					<p>AAV transduction of neurons in primary cultures or in mouse tissues</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230029-00</p>
				</td>
				<td>
					
					<p>17.01.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Jörg Hummerjohann</p>
					<p>Agroscope Liebefeld</p>
					<p>Schwarzenburgstrasse<br>3003 Bern</p>
				</td>
				<td>
					
					<p>Charakterisierung von enterohämorrhagischen E. coli (EHEC) Isolaten</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230030-00</p>
				</td>
				<td>
					
					<p>26.01.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Andre Schaller</p>
					<p>Universität Bern, Department for BioMedical Research (DBMR)</p>
					<p>Murtenstrasse 24<br>3008 Bern</p>
				</td>
				<td>
					
					<p>Functional characterisation of genes implicated in neurological and neurodevelopmental disorders</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230031-00</p>
				</td>
				<td>
					
					<p>30.01.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Lucas Boeck</p>
					<p>Departement Biomedizin (DBM), Hebelstrasse, Universitätsspital Basel</p>
					<p>Spitalstrasse 41<br>4056 Basel</p>
				</td>
				<td>
					
					<p>Drug tolerance in Mycobacterium tuberculosis </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230032-00</p>
				</td>
				<td>
					
					<p>31.01.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Audrey Berger</p>
					<p>SEED Biosciences SA</p>
					<p>Route de la Corniche 6<br>1066 Epalinges</p>
				</td>
				<td>
					
					<p>Biology_lab_1</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230033-00</p>
				</td>
				<td>
					
					<p>31.01.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Renier Myburgh</p>
					<p>Phire Therapeutics</p>
					<p>Wagistrasse 18<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>PHR-001 preclinical</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230034-00</p>
				</td>
				<td>
					
					<p>01.02.2023</p>
				</td>
				<td>
					
					<p>FR</p>
				</td>
				<td>
					
					<p>Csaba Szabo</p>
					<p>University of Fribourg, Faculty of Science and Medicine | Department of Medicine, Chair of Pharmacology | Building PER 17</p>
					<p>Ch. du Musée<br>1700 Fribourg</p>
				</td>
				<td>
					
					<p>PARP activation in acute lung injury</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230035-00</p>
				</td>
				<td>
					
					<p>02.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Kurt Tobler</p>
					<p>Universität Zürich | Virologisches Institut</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Klonierung und Expression von viralen Genen in bakteriellen Plasmiden</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230036-00</p>
				</td>
				<td>
					
					<p>02.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Christian Zollinger</p>
					<p>Labor Zollinger AG</p>
					<p>Grabenstrasse 1<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Diagnostische Tätigkeit mit Organismen der Gruppe 1 und 2 im geschlossenen System</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230037-00</p>
				</td>
				<td>
					
					<p>02.02.2023</p>
				</td>
				<td>
					
					<p>NE</p>
				</td>
				<td>
					
					<p>Gwenaël Cudennec</p>
					<p>Prolab – Viteos SA</p>
					<p>Collège 33<br>2300 La Chaux-de-Fonds</p>
				</td>
				<td>
					
					<p>Analyser la qualité de l’eau de boisson sur les plans chimique et bactériologique </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230038-00</p>
				</td>
				<td>
					
					<p>02.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Ralf Thoma</p>
					<p>F. Hoffmann-La Roche AG, pRED Therapeutic Modalities</p>
					<p>Grenzacherstrasse<br>4070 Basel</p>
				</td>
				<td>
					
					<p>Protein Expression und Fermentation für die Forschung</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230039-00</p>
				</td>
				<td>
					
					<p>03.02.2023</p>
				</td>
				<td>
					
					<p>BS</p>
				</td>
				<td>
					
					<p>Julia Kröpfl</p>
					<p>Departement für Sport, Bewegung und Gesundheit (DSBG), Universität Basel</p>
					<p>Grosse Allee 6<br>4052 Basel</p>
				</td>
				<td>
					
					<p>Zelluntersuchungen in der Sportmedizin</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230041-00</p>
				</td>
				<td>
					
					<p>06.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Bernhard Gentner</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>setting up for the transfeftion cells </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230042-00</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>TI</p>
				</td>
				<td>
					
					<p>Michele Orsi</p>
					<p>TicInsect SA</p>
					<p>Via Industria 12<br>6710 Biasca</p>
				</td>
				<td>
					
					<p>Allevamento di Hermetia illucens, produzione materie prime per mangimi e frass</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230043-01</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anna Sophie Ramsauer</p>
					<p>Universität Zürich | Virologisches Institut</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Molecular characterization of Equine Papillomavirus infections</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230044-00</p>
				</td>
				<td>
					
					<p>07.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Anna Sophie Ramsauer</p>
					<p>Universität Zürich | Virologisches Institut</p>
					<p>Winterthurerstrasse<br>8057 Zürich</p>
				</td>
				<td>
					
					<p>Characterization of equine liver viruses</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230045-00</p>
				</td>
				<td>
					
					<p>09.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Alexander Zimmermann</p>
					<p>USZ, Experimentelle Gefässchirurgie</p>
					<p>Wagistrasse 2<br>8952 8952 Schlieren</p>
				</td>
				<td>
					
					<p>Molecular nature of baroreceptors in human aortic arch</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230046-00</p>
				</td>
				<td>
					
					<p>09.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Matthias Lutolf</p>
					<p>Roche Glycart AG | Roche Innovation Center Zurich | Roche Pharma Research and Early Development</p>
					<p>Wagistrasse 10<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Organoid Farm</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230047-00</p>
				</td>
				<td>
					
					<p>13.02.2023</p>
				</td>
				<td>
					
					<p>GE</p>
				</td>
				<td>
					
					<p>Richie Kohman</p>
					<p>Fondation campus Biotech Geneva</p>
					<p>Chemin des Mines<br>1202 Genève</p>
				</td>
				<td>
					
					<p>Creation of viral vectors for investigation of rodent brain structure and fonction</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230048-00</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>AG</p>
				</td>
				<td>
					
					<p>Mathias Blum</p>
					<p>Syngenta Crop Protection AG</p>
					<p>Schaffhauserstrasse 101<br>4123 Stein</p>
				</td>
				<td>
					
					<p>Activities with bacteria with risk group 2 and 3</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230049-00</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cameron Boggon</p>
					<p>ETHZ, Departement MATL, Laboratory of Soft Materials and Interfaces</p>
					<p>Vladimir-Prelog-Weg 5<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Characterisation of Bacillus subtilis spore germination using sCAPA</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230050-00</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cameron Boggon</p>
					<p>ETHZ, Departement MATL, Laboratory of Soft Materials and Interfaces</p>
					<p>Vladimir-Prelog-Weg 5<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Inhibition of Staphylococci colonisation in the nose</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230051-00</p>
				</td>
				<td>
					
					<p>14.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Cameron Boggon</p>
					<p>ETHZ, Departement MATL, Laboratory of Soft Materials and Interfaces</p>
					<p>Vladimir-Prelog-Weg 5<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>Engineering the structure of multispecies bacterial communities using sCAPA and DNA aptamers</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230052-00</p>
				</td>
				<td>
					
					<p>15.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Laurine Rijsbergen</p>
					<p>hemotune AG</p>
					<p>Wagistrasse 27<br>8952 Schlieren</p>
				</td>
				<td>
					
					<p>Study with adeno-associated virus </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230053-00</p>
				</td>
				<td>
					
					<p>15.02.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Jean-Louis Reymond</p>
					<p>Universität Bern, Departement für Chemie, Biochemie und Pharmazie</p>
					<p>Freiestrasse<br>3012 Bern</p>
				</td>
				<td>
					
					<p>Evaluation of the toxicity and efficacy of antimicrobial peptides on G.mellonella larvae</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230054-00</p>
				</td>
				<td>
					
					<p>17.02.2023</p>
				</td>
				<td>
					
					<p>BE</p>
				</td>
				<td>
					
					<p>Geneviève Escher</p>
					<p>Universität Bern, Department for BioMedical Research (DBMR)</p>
					<p>Freiburgstrasse<br>3010 Bern</p>
				</td>
				<td>
					
					<p>Understanding early pathogenesis events in the lysosomal storage disease nephropathic cystinosis and the role of transporters in kidney function</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230055-00</p>
				</td>
				<td>
					
					<p>17.02.2023</p>
				</td>
				<td>
					
					<p>VD</p>
				</td>
				<td>
					
					<p>Fernanda Herrera</p>
					<p>CHUV – Centre hospitalier universitaire vaudois</p>
					<p>Rue du Bugnon 25A Bâtiment Agora centre de recherche oncologique<br>1011 Lausanne</p>
				</td>
				<td>
					
					<p>Effects of irradiation in senescence </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230056-00</p>
				</td>
				<td>
					
					<p>20.02.2023</p>
				</td>
				<td>
					
					<p>ZH</p>
				</td>
				<td>
					
					<p>Yohei Yamauchi</p>
					<p>ETHZ, Institute of Pharmaceutical Sciences (IPW), Group Prof. Dr. Yohei Yamauchi</p>
					<p>Vladimir-Prelog-Weg 3<br>8093 Zürich</p>
				</td>
				<td>
					
					<p>General biosafety level 1 work </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230057-00</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Matthias Lutolf</p>
					<p>F. Hoffmann-La Roche AG, ITB (Institute for Translational Bioengineering)</p>
				</td>
				<td>
					
					<p>Roche Institute Translational Bioengineering (ITB)</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230058-00</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>David Penton Ribas</p>
					<p>Universität Zürich Department of Molecular Life Sciences</p>
				</td>
				<td>
					
					<p>Culture of primary cells from Adrenal adenoma Patients</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230059-00</p>
				</td>
				<td>
					
					<p>23.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Michael Müller</p>
					<p>Universität Bern, Department for BioMedical Research (DBMR)</p>
				</td>
				<td>
					
					<p>Research focusing on women’s health</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230060-00</p>
				</td>
				<td>
					
					<p>24.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Patrick Kunz</p>
					<p>Peptone</p>
				</td>
				<td>
					
					<p>Identification and modulation of biological pathways using cell based model systems</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230061-00</p>
				</td>
				<td>
					
					<p>24.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Xi Zhang</p>
					<p>Superlab Suisse Epalinges SA</p>
				</td>
				<td>
					
					<p>Mise à disposition laboratoires privés</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230062-00</p>
				</td>
				<td>
					
					<p>24.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Edoardo Mazza</p>
					<p>ETHZ, Departement MAVT</p>
				</td>
				<td>
					
					<p>ETHeart – Endothelial cell project</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230063-00</p>
				</td>
				<td>
					
					<p>24.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Edoardo Mazza</p>
					<p>ETHZ, Departement MAVT</p>
				</td>
				<td>
					
					<p>Skintegrity</p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230064-00</p>
				</td>
				<td>
					
					<p>24.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Stephanie Jungmichel</p>
					<p>CDR-Life AG</p>
				</td>
				<td>
					
					<p>Co-cultivation of immune cells with feeder cell lines </p>
				</td>
			</tr>
			<tr>
				
				
				<td>
					
					<p>A230065-00</p>
				</td>
				<td>
					
					<p>28.02.2023</p>
				</td>
				<td>
					
					<p></p>
				</td>
				<td>
					
					<p>Mark Lendenmann</p>
					<p>ZHAW, Life Sciences und Facility Management</p>
				</td>
				<td>
					
					<p>Monitoring mit Spürhunden und Bekämpfung von Japankäferlarven mit insektenparasitischen Nematoden</p>
				</td>
			</tr>
		</table></div>
<p>L’ordonnance du 9 mai 2012 sur l’utilisation confinée (OUC; RS <i>814.912</i>) constitue la base légale pour la publication.</p>
<p>Les personnes intéressées peuvent consulter les dossiers non confidentiels auprès de l’OFEV, division sol et biotechnologie, Worblentalstrasse 68, 3063 Ittigen </p>
<p>(www.umwelt-schweiz.ch).</p>
<p class=" man-text-align-left ">Veuillez vous annoncer auparavant au Bureau de Biotechnologie de <br>la Confédération, c/o OFEV, téléphone +41 58 463 55 99, fax +41 58 463 79 78, contact.biotech@bafu.admin.ch. </p>
<p></p>
<div class="table"><table border="1">
			
			
			<tr>
				
				
				<td>
					
					<p>20 mars 2023</p>
				</td>
				<td>
					
					<p>Office fédéral de l’environnement:</p>
					<p>Bureau de Biotechnologie de la Confédération</p>
				</td>
			</tr>
		</table></div>
</div></div></body>
</html>
